← Back to Search

Neural Interface

Auditory Implant Evaluation for Hearing Loss

N/A
Recruiting
Led By Mahan Azadpour
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants.
No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to participate in behavioral and electrophysiological experiments.
Must not have
Severe neurological disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (visit 1 - average visit length is about 3 hours)
Awards & highlights

Summary

This trial will study the hearing of adults and kids with hearing impairments who use implants to hear. It will evaluate how well the implants work.

Who is the study for?
This trial is for hearing-impaired adults and children over 2 years old who use cochlear or auditory brainstem implants. Participants must not have other cognitive or communicative disorders, severe neurological issues, and their implant's electrodes must be functional without causing discomfort.
What is being tested?
The study investigates how well people with cochlear or auditory brainstem implants process sounds. It involves behavioral and electrophysiological experiments conducted in a lab setting to evaluate the effectiveness of these devices in restoring hearing functions.
What are the potential side effects?
Since this is an observational study focusing on auditory processing, there are no direct side effects from interventions like drugs or surgeries. However, participants may experience fatigue or discomfort during testing procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am hearing impaired and use an ABI or cochlear implant.
Select...
I have no cognitive disorders except for hearing impairment and can visit the lab.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a severe neurological disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (visit 1 - average visit length is about 3 hours)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (visit 1 - average visit length is about 3 hours) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of Correctly-Identified Speech Materials
Percent of Correctly-Identified Stimuli Characteristics when Two or More Stimuli are Presented

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hearing-Impaired Individuals who use Cochlear Implants or Auditory Brainstem Implant (ABI) DevicesExperimental Treatment1 Intervention
Two types of measurements will be obtained: 1. Perceptual: one or more sounds are presented and a behavioral response is collected (e.g., judgements of loudness, pitch or other differences between the sounds, or identifying the word or sentence that was said). 2. Physiological: noninvasive electrophysiological recordings of nervous system activity.

Find a Location

Who is running the clinical trial?

Cochlear AmericasUNKNOWN
NYU Langone HealthLead Sponsor
1,397 Previous Clinical Trials
861,642 Total Patients Enrolled
16 Trials studying Hearing Loss
2,410 Patients Enrolled for Hearing Loss
Mahan AzadpourPrincipal InvestigatorNYU Langone Health

Media Library

Electrode-Neural Interface (Neural Interface) Clinical Trial Eligibility Overview. Trial Name: NCT05810220 — N/A
Hearing Loss Research Study Groups: Hearing-Impaired Individuals who use Cochlear Implants or Auditory Brainstem Implant (ABI) Devices
Hearing Loss Clinical Trial 2023: Electrode-Neural Interface Highlights & Side Effects. Trial Name: NCT05810220 — N/A
Electrode-Neural Interface (Neural Interface) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05810220 — N/A
~36 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top